Click here to get full coverage on Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles - TMX Newsfile

Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles  TMX Newsfile

Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles - TMX Newsfile

Click here to get full coverage on Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water (undefined:LFCR) - Seeking Alpha

Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water (undefined:LFCR)  Seeking Alpha

Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water (undefined:LFCR) - Seeking Alpha

Click here to get full coverage on Attention Long-Term Shareholders of Integer Holdings Corp, - GlobeNewswire

Attention Long-Term Shareholders of Integer Holdings Corp,  GlobeNewswire

Attention Long-Term Shareholders of Integer Holdings Corp, - GlobeNewswire

Click here to get full coverage on Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation  ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Click here to get full coverage on Here’s Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3 - Yahoo Finance

Here’s Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3  Yahoo Finance

Here’s Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3 - Yahoo Finance

Click here to get full coverage on Hedge funds investors in Lifecore Biomedical, Inc. (NASDAQ:LFCR) lost 14% last week but have reaped the benefits of longer-term growth - simplywall.st

Hedge funds investors in Lifecore Biomedical, Inc. (NASDAQ:LFCR) lost 14% last week but have reaped the benefits of longer-term growth  simplywall.st

Hedge funds investors in Lifecore Biomedical, Inc. (NASDAQ:LFCR) lost 14% last week but have reaped the benefits of longer-term growth - simplywall.st

Click here to get full coverage on Analysts Conflicted on These Healthcare Names: Lifecore Biomedical (LFCR) and Xenon (XENE) - The Globe and Mail

Analysts Conflicted on These Healthcare Names: Lifecore Biomedical (LFCR) and Xenon (XENE)  The Globe and Mail

Analysts Conflicted on These Healthcare Names: Lifecore Biomedical (LFCR) and Xenon (XENE) - The Globe and Mail

Click here to get full coverage on (LFCR) Movement as an Input in Quant Signal Sets - Stock Traders Daily

(LFCR) Movement as an Input in Quant Signal Sets  Stock Traders Daily

(LFCR) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Click here to get full coverage on Big Picture: Why LFCR stock is popular among millennials - Market Growth Review & AI Powered Trade Plan Recommendations - Bộ Nội Vụ

Big Picture: Why LFCR stock is popular among millennials - Market Growth Review & AI Powered Trade Plan Recommendations  Bộ Nội Vụ

Big Picture: Why LFCR stock is popular among millennials - Market Growth Review & AI Powered Trade Plan Recommendations - Bộ Nội Vụ

Click here to get full coverage on Lifecore Biomedical: The Turnaround Is Just Getting Started (NASDAQ:LFCR) - Seeking Alpha

Lifecore Biomedical: The Turnaround Is Just Getting Started (NASDAQ:LFCR)  Seeking Alpha

Lifecore Biomedical: The Turnaround Is Just Getting Started (NASDAQ:LFCR) - Seeking Alpha

Click here to get full coverage on Shareholders in Lifecore Biomedical (NASDAQ:LFCR) are in the red if they invested five years ago - Yahoo Finance

Shareholders in Lifecore Biomedical (NASDAQ:LFCR) are in the red if they invested five years ago  Yahoo Finance

Shareholders in Lifecore Biomedical (NASDAQ:LFCR) are in the red if they invested five years ago - Yahoo Finance

Click here to get full coverage on Investors in Lifecore Biomedical (NASDAQ:LFCR) from five years ago are still down 24%, even after 14% gain this past week - simplywall.st

Investors in Lifecore Biomedical (NASDAQ:LFCR) from five years ago are still down 24%, even after 14% gain this past week  simplywall.st

Investors in Lifecore Biomedical (NASDAQ:LFCR) from five years ago are still down 24%, even after 14% gain this past week - simplywall.st

Click here to get full coverage on Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK) and Lifecore Biomedical (LFCR) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK) and Lifecore Biomedical (LFCR)  The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK) and Lifecore Biomedical (LFCR) - The Globe and Mail

Click here to get full coverage on Lifecore Biomedical: A Disconnect Between Share Price And Business Progress (LFCR) - Seeking Alpha

Lifecore Biomedical: A Disconnect Between Share Price And Business Progress (LFCR)  Seeking Alpha

Lifecore Biomedical: A Disconnect Between Share Price And Business Progress (LFCR) - Seeking Alpha

Click here to get full coverage on Laughing Water Capital’s View on Lifecore Biomedical (LFCR) - Yahoo Finance

Laughing Water Capital’s View on Lifecore Biomedical (LFCR)  Yahoo Finance

Laughing Water Capital’s View on Lifecore Biomedical (LFCR) - Yahoo Finance

Click here to get full coverage on One Lifecore Biomedical Insider Raised Their Stake In The Previous Year - Yahoo Finance

One Lifecore Biomedical Insider Raised Their Stake In The Previous Year  Yahoo Finance

One Lifecore Biomedical Insider Raised Their Stake In The Previous Year - Yahoo Finance

Click here to get full coverage on Rating Downgrade: Lifecore, Ready To Go, But Problems Remain (NASDAQ:LFCR) - Seeking Alpha

Rating Downgrade: Lifecore, Ready To Go, But Problems Remain (NASDAQ:LFCR)  Seeking Alpha

Rating Downgrade: Lifecore, Ready To Go, But Problems Remain (NASDAQ:LFCR) - Seeking Alpha

Click here to get full coverage on Understanding the Setup: (LFCR) and Scalable Risk - Stock Traders Daily

Understanding the Setup: (LFCR) and Scalable Risk  Stock Traders Daily

Understanding the Setup: (LFCR) and Scalable Risk - Stock Traders Daily

Click here to get full coverage on Why Lifecore is being added to Nasdaq’s biotech and pharma index - Stock Titan

Why Lifecore is being added to Nasdaq’s biotech and pharma index  Stock Titan

Why Lifecore is being added to Nasdaq’s biotech and pharma index - Stock Titan

Click here to get full coverage on Lifecore Biomedical Reports Financial Results for the Three - GlobeNewswire

Lifecore Biomedical Reports Financial Results for the Three  GlobeNewswire

Lifecore Biomedical Reports Financial Results for the Three - GlobeNewswire

Click here to get full coverage on Lifecore Biomedical: Our Fill-Finish CDMO (LFCR) - Seeking Alpha

Lifecore Biomedical: Our Fill-Finish CDMO (LFCR)  Seeking Alpha

Lifecore Biomedical: Our Fill-Finish CDMO (LFCR) - Seeking Alpha

Click here to get full coverage on Stock Analysis: Why LFCR stock is seen as undervalued - 2025 EndofYear Setup & Long-Term Safe Return Strategies - Bộ Nội Vụ

Stock Analysis: Why LFCR stock is seen as undervalued - 2025 EndofYear Setup & Long-Term Safe Return Strategies  Bộ Nội Vụ

Stock Analysis: Why LFCR stock is seen as undervalued - 2025 EndofYear Setup & Long-Term Safe Return Strategies - Bộ Nội Vụ

Click here to get full coverage on Lifecore Biomedical (NASDAQ: LFCR) to webcast Jefferies London, Stephens Nashville - Stock Titan

Lifecore Biomedical (NASDAQ: LFCR) to webcast Jefferies London, Stephens Nashville  Stock Titan

Lifecore Biomedical (NASDAQ: LFCR) to webcast Jefferies London, Stephens Nashville - Stock Titan

Click here to get full coverage on Market Pulse: Is LFCR stock vulnerable to regulatory risks - 2025 Support & Resistance & High Accuracy Investment Signals - Bộ Nội Vụ

Market Pulse: Is LFCR stock vulnerable to regulatory risks - 2025 Support & Resistance & High Accuracy Investment Signals  Bộ Nội Vụ

Market Pulse: Is LFCR stock vulnerable to regulatory risks - 2025 Support & Resistance & High Accuracy Investment Signals - Bộ Nội Vụ

Click here to get full coverage on 3 Events: Lifecore to Present at PODD, CPHI Frankfurt & Pharma Outsourcing Summit Oct–Nov 2025 - Stock Titan

3 Events: Lifecore to Present at PODD, CPHI Frankfurt & Pharma Outsourcing Summit Oct–Nov 2025  Stock Titan

3 Events: Lifecore to Present at PODD, CPHI Frankfurt & Pharma Outsourcing Summit Oct–Nov 2025 - Stock Titan

Click here to get full coverage on Bank Watch: Is LFCR stock positioned well for digital economy - CPI Data & Verified Momentum Stock Alerts - Bộ Nội Vụ

Bank Watch: Is LFCR stock positioned well for digital economy - CPI Data & Verified Momentum Stock Alerts  Bộ Nội Vụ

Bank Watch: Is LFCR stock positioned well for digital economy - CPI Data & Verified Momentum Stock Alerts - Bộ Nội Vụ

Click here to get full coverage on Published on: 2026-01-11 11:06:08 - Улправда

Published on: 2026-01-11 11:06:08  Улправда

Published on: 2026-01-11 11:06:08 - Улправда

Click here to get full coverage on Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR) - Yahoo Finance

Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR)  Yahoo Finance

Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR) - Yahoo Finance

Click here to get full coverage on Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation  ACCESS Newswire

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Click here to get full coverage on Lower electric bills for Tucson - KVOA

Lower electric bills for Tucson - KVOA

Click here to get full coverage on Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer - GlobeNewswire

Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer  GlobeNewswire

Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer - GlobeNewswire

Click here to get full coverage on Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025 - GlobeNewswire

Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025  GlobeNewswire

Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025 - GlobeNewswire

Click here to get full coverage on Lifecore Biomedical to Attend Two Upcoming Investor Conferences in November 2025 - Quiver Quantitative

Lifecore Biomedical to Attend Two Upcoming Investor Conferences in November 2025  Quiver Quantitative

Lifecore Biomedical to Attend Two Upcoming Investor Conferences in November 2025 - Quiver Quantitative

Click here to get full coverage on Lifecore Biomedical to be Added to Nasdaq Biotech Index - Sahm

Lifecore Biomedical to be Added to Nasdaq Biotech Index  Sahm

Lifecore Biomedical to be Added to Nasdaq Biotech Index - Sahm

Click here to get full coverage on Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights  Business Wire

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire

Click here to get full coverage on Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference  GlobeNewswire

Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Click here to get full coverage on Is LFCR stock trading at a premium valuation - Quarterly Investment Review & Free High Return Stock Watch Alerts - Улправда

Is LFCR stock trading at a premium valuation - Quarterly Investment Review & Free High Return Stock Watch Alerts  Улправда

Is LFCR stock trading at a premium valuation - Quarterly Investment Review & Free High Return Stock Watch Alerts - Улправда

Click here to get full coverage on Is LFCR stock trading at a premium valuation - 2025 Top Decliners & Fast Momentum Entry Tips - Улправда

Is LFCR stock trading at a premium valuation - 2025 Top Decliners & Fast Momentum Entry Tips  Улправда

Is LFCR stock trading at a premium valuation - 2025 Top Decliners & Fast Momentum Entry Tips - Улправда

Click here to get full coverage on Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer - GlobeNewswire

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer  GlobeNewswire

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer - GlobeNewswire

Click here to get full coverage on KeyBanc maintains Sector Weight rating on Lifecore Biomedical stock - Investing.com

KeyBanc maintains Sector Weight rating on Lifecore Biomedical stock  Investing.com

KeyBanc maintains Sector Weight rating on Lifecore Biomedical stock - Investing.com

Click here to get full coverage on About Us - FinancialContent

About Us - FinancialContent

Click here to get full coverage on Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)  GlobeNewswire

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Click here to get full coverage on Institution Moves: Is LFCR stock trading at a premium valuation - 2025 Technical Patterns & Expert Approved Trade Ideas - Bộ Nội Vụ

Institution Moves: Is LFCR stock trading at a premium valuation - 2025 Technical Patterns & Expert Approved Trade Ideas  Bộ Nội Vụ

Institution Moves: Is LFCR stock trading at a premium valuation - 2025 Technical Patterns & Expert Approved Trade Ideas - Bộ Nội Vụ

Click here to get full coverage on Lifecore Biomedical to Participate in Upcoming Investor Conferences - GlobeNewswire

Lifecore Biomedical to Participate in Upcoming Investor Conferences  GlobeNewswire

Lifecore Biomedical to Participate in Upcoming Investor Conferences - GlobeNewswire

Click here to get full coverage on Lifecore Biomedical Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance

Lifecore Biomedical Full Year 2025 Earnings: EPS Beats Expectations  Yahoo Finance

Lifecore Biomedical Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance

Click here to get full coverage on Why LFCR stock remains a top recommendation - July 2025 Chart Watch & Verified Momentum Stock Watchlist - Bộ Nội Vụ

Why LFCR stock remains a top recommendation - July 2025 Chart Watch & Verified Momentum Stock Watchlist  Bộ Nội Vụ

Why LFCR stock remains a top recommendation - July 2025 Chart Watch & Verified Momentum Stock Watchlist - Bộ Nội Vụ

Click here to get full coverage on Earnings call transcript: Lifecore Biomedical beats Q3 2025 forecasts - Investing.com

Earnings call transcript: Lifecore Biomedical beats Q3 2025 forecasts  Investing.com

Earnings call transcript: Lifecore Biomedical beats Q3 2025 forecasts - Investing.com

Click here to get full coverage on Lifecore and PolyPeptide partner on integrated peptide manufacturing By Investing.com - Investing.com Nigeria

Lifecore and PolyPeptide partner on integrated peptide manufacturing By Investing.com  Investing.com Nigeria

Lifecore and PolyPeptide partner on integrated peptide manufacturing By Investing.com - Investing.com Nigeria

Click here to get full coverage on Press Telegram - FinancialContent

Press Telegram - FinancialContent

Click here to get full coverage on Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference  The Manila Times

Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Click here to get full coverage on Townhall - FinancialContent

Townhall - FinancialContent

Click here to get full coverage on Lifecore Biomedical: An Interesting CDMO Pure Play (NASDAQ:LFCR) - Seeking Alpha

Lifecore Biomedical: An Interesting CDMO Pure Play (NASDAQ:LFCR)  Seeking Alpha

Lifecore Biomedical: An Interesting CDMO Pure Play (NASDAQ:LFCR) - Seeking Alpha

Click here to get full coverage on LFCR Stock Price and Chart — NASDAQ:LFCR - TradingView — Track All Markets

LFCR Stock Price and Chart — NASDAQ:LFCR  TradingView — Track All Markets

LFCR Stock Price and Chart — NASDAQ:LFCR - TradingView — Track All Markets

Click here to get full coverage on Lifecore Biomedical (LFCR) Earnings Report: Key Numbers & Transcript Summary - StockInvest.us

Lifecore Biomedical (LFCR) Earnings Report: Key Numbers & Transcript Summary  StockInvest.us

Lifecore Biomedical (LFCR) Earnings Report: Key Numbers & Transcript Summary - StockInvest.us

Click here to get full coverage on Lifecore Biomedical: Finally A 'Pure Play' CDMO Business - Seeking Alpha

Lifecore Biomedical: Finally A 'Pure Play' CDMO Business  Seeking Alpha

Lifecore Biomedical: Finally A 'Pure Play' CDMO Business - Seeking Alpha

Click here to get full coverage on Lifecore Biomedical (LFCR) Stock Price, News & Analysis $LFCR - MarketBeat

Lifecore Biomedical (LFCR) Stock Price, News & Analysis $LFCR  MarketBeat

Lifecore Biomedical (LFCR) Stock Price, News & Analysis $LFCR - MarketBeat

Click here to get full coverage on LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm - FinancialContent

LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm  FinancialContent

LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm - FinancialContent

Click here to get full coverage on Lifecore Biomedical, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the LFCR Class Action Lawsuit - FinancialContent

Lifecore Biomedical, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the LFCR Class Action Lawsuit  FinancialContent

Lifecore Biomedical, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the LFCR Class Action Lawsuit - FinancialContent

Click here to get full coverage on Kirby McInerney LLP Reminds Lifecore Biomedical, Inc. (LFCR) Investors of Class Action Filing and Encourages Investors to Contact the Firm - FinancialContent

Kirby McInerney LLP Reminds Lifecore Biomedical, Inc. (LFCR) Investors of Class Action Filing and Encourages Investors to Contact the Firm  FinancialContent

Kirby McInerney LLP Reminds Lifecore Biomedical, Inc. (LFCR) Investors of Class Action Filing and Encourages Investors to Contact the Firm - FinancialContent

Click here to get full coverage on Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Lifecore Biomedical, Inc. (LFCR) - FinancialContent

Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Lifecore Biomedical, Inc. (LFCR)  FinancialContent

Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Lifecore Biomedical, Inc. (LFCR) - FinancialContent

Click here to get full coverage on ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical - GlobeNewswire

ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical  GlobeNewswire

ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical - GlobeNewswire

Click here to get full coverage on Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR) - FinancialContent

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR)  FinancialContent

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR) - FinancialContent

Click here to get full coverage on Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent

Rockford Register Star: Local News, Politics & Sports in Rockford, IL  FinancialContent

Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent

Click here to get full coverage on Law Offices of Howard G. Smith Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors - FinancialContent

Law Offices of Howard G. Smith Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors  FinancialContent

Law Offices of Howard G. Smith Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of Investors - FinancialContent

Click here to get full coverage on Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing - Medical Design & Outsourcing

Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing  Medical Design & Outsourcing

Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing - Medical Design & Outsourcing

Click here to get full coverage on Lifecore Biomedical returns to Minnesota and the public market - Star Tribune

Lifecore Biomedical returns to Minnesota and the public market  Star Tribune

Lifecore Biomedical returns to Minnesota and the public market - Star Tribune

Click here to get full coverage on Users - FinancialContent

Users - FinancialContent

Click here to get full coverage on Lifecore Biomedical (NASDAQ:LFCR) Upgraded at Zacks Research - Defense World

Lifecore Biomedical (NASDAQ:LFCR) Upgraded at Zacks Research  Defense World

LFCR

Price Chart

Key Statistics

Top 10 Holdings Distribution

Technicals

About LFCR

Latest News

Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles - TMX Newsfile

Lifecore Biomedical: Wins Should Blow Previous 'New Business' Estimates Out Of The Water (undefined:LFCR) - Seeking Alpha

Attention Long-Term Shareholders of Integer Holdings Corp, - GlobeNewswire

Advanced Charts

Fund Information